DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Systemic lupus erythematosus	R-HSA-977105	map05322	hymecromone	72894	drug-path
Primary immunodeficiency	R-HSA-5601905	map05340	hymecromone	72894	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	hymecromone	72894	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	hymecromone	72894	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	hymecromone	72894	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	hymecromone	72894	drug-path
Amyotrophic lateral sclerosis (ALS)	Q8NDH6-2	0	midecamycin	4039	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	midecamycin	4039	drug-path
Colorectal cancer	R-HSA-4791275	map05210	midecamycin	4039	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	moroxydine	71655	drug-path
RNA polymerase	R-HSA-73864	map03020	moroxydine	71655	drug-path
Alzheimer's disease	R-HSA-1643685	0	pempidine	6603	drug-path
Leukocyte transendothelial migration	R-HSA-8950732	map04670	pempidine	6603	drug-path
Olfactory transduction	R-HSA-9751605	map04740	pempidine	6603	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	pempidine	6603	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	pempidine	6603	drug-path
Huntington's disease	R-HSA-1643685	0	pempidine	6603	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	pempidine	6603	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	pempidine	6603	drug-path
Cell cycle	R-HSA-1640170	map04110	pempidine	6603	drug-path